QNR
TW EN

scroll

Go Top

臺中榮民總醫院 臨床試驗中心Taichung Veterans General Hospital Clinical Trials Center

  • Total Beds1,622
  • Total Doctors934
  • Address1650 Taiwan Boulevard Sec. 4,Xitun,Taichung City 407
  • Phone Number+886-423592525 ext. 4780

1. Smart Healthcare and Decentralized Trial System

2. Development in Cellular Therapy and Innovative Medical Technology

3. Comprehensive Academic Support System from Research Development to Implementation

Site Introduction

Taichung Veterans General Hospital (TCVGH) Clinical Trials Center was established in 2009 and was granted national-level excellence as a clinical trial center in 2024. Through the highest ethical and scientific standards, we promote clinical research with cutting-edge information technology and professional academic support, facilitating medical discoveries and efficacy verification.
We are committed to:
1. Facilitating communication channels between industry sponsors and TCVGH researchers.
2. Providing infrastructure for clinical trials (researchers and facilities).
3. convene IRB consortium in excellent CTCs as well as the other medical centers
4. Promoting international collaboration with academic institutions and industry partners.
5. Maintaining good communication with the Ministry of Health and Welfare's "Clinical Trial Excellence Program" (CTEP).
As Taiwan enters the 21st century, it leaves a profound impression on the world with its enormous potential in medicine, biotechnology, and information technology. In the future, domestic and international pharmaceutical companies, government research institutions, and private entities seeking academic medical centers to validate new diagnostics and therapies will find that TCVGH has positioned itself at the forefront of innovative clinical trials and research.

Clinicl Trial Expertise

Clinical trial for all major organ system disease of all vital organ systems

International Accreditation

美國臨床研究受試者保護評鑑協會AAHRPP認證(Full Reaccreditation)
FERCAP國際認證
美國醫療資訊暨管理系統協會(HIMSS)Stage 7 認證

GCP Inspection/audit

US FDA
Taiwan FDA

What types of clinical trial do you conduct?

Publications

CTC

1

Connelly, K., Kandane-Rathnayake, R., Hoi, A., Louthrenoo, W., Hamijoyo, L., Luo, S. F., Wu, Y. J., Cho, J., Lateef, A., Lau, C. S., Chen, Y. H., Navarra, S., Zamora, L., Li, Z., An, Y., Sockalingam, S., Hao, Y., Zhang, Z., Chan, M., Katsumata, Y., … Morand, E. F. (2023). Association of Modified Systemic Lupus Erythematosus Responder Index Attainment With Long-Term Clinical Outcomes: A Five-Year Prospective Study. Arthritis & rheumatology (Hoboken, N.J.), 75(3), 401–410. https://doi.org/10.1002/art.42350

2

Fu, J. C., Fu, P. K., & Cheng, Y. Y. (2022). Benefits of Cycling Wheelchair Training for Elderly with Physical Disability: A Prospective Cohort Study. International journal of environmental research and public health, 19(24), 16773. https://doi.org/10.3390/ijerph192416773

3

Ahn, M. J., Kim, H. R., Yang, J. C. H., Han, J. Y., Li, J. Y., Hochmair, M. J., Chang, G. C., Delmonte, A., Lee, K. H., Campelo, R. G., Gridelli, C., Spira, A. I., Califano, R., Griesinger, F., Ghosh, S., Felip, E., Kim, D. W., Liu, Y., Zhang, P., Popat, S., … Camidge, D. R. (2022). Efficacy and Safety of Brigatinib Compared With Crizotinib in Asian vs. Non-Asian Patients With Locally Advanced or Metastatic ALK-Inhibitor-Naive ALK+ Non-Small Cell Lung Cancer: Final Results From the Phase III ALTA-1L Study. Clinical lung cancer, 23(8), 720–730. https://doi.org/10.1016/j.cllc.2022.07.008

4

Lee, C. H., Tsai, C. I., Su, Y. C., Lin, S. Y., Lee, I. T., & Li, T. C. (2022). Traditional Chinese medicine body constitution predicts new-onset diabetic albuminuria in patients with type 2 diabetes: Taichung diabetic body constitution prospective cohort study. Medicine, 101(50), e32342. https://doi.org/10.1097/MD.0000000000032342

5

Lau, C. S., Chen, Y. H., Lim, K., de Longueville, M., Arendt, C., & Winthrop, K. (2021). Tuberculosis and viral hepatitis in patients treated with certolizumab pegol in Asia-Pacific countries and worldwide: real-world and clinical trial data. Clinical rheumatology, 40(3), 867–875. https://doi.org/10.1007/s10067-020-05248-4

6

Wang, Y. J., Chan, Y. N., Jheng, Y. W., Wu, C. J., Lin, M. W., Tseng, L. M., Tsai, Y. F., & Liu, L. C. (2021). Chemotherapy-induced peripheral neuropathy in newly diagnosed breast cancer survivors treated with taxane: a prospective longitudinal study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 29(6), 2959–2971. https://doi.org/10.1007/s00520-020-05796-0

7

Fu, P. K., Wei, Y. F., Sheu, C. C., Wang, C. Y., Hsu, C. K., Chen, C. M., Chen, W. C., & Yang, K. Y. (2020). Effect of Tiotropium Soft Mist Inhalers on Dynamic Changes in Lung Mechanics of Patients with Chronic Obstructive Pulmonary Disease Receiving Mechanical Ventilation: A Prospective Pilot Study. Pharmaceutics, 13(1), 51. https://doi.org/10.3390/pharmaceutics13010051

8

Lu, Y. S., Lee, K. S., Chao, T. Y., Tseng, L. M., Chitapanarux, I., Chen, S. C., Liu, C. T., Sohn, J., Kim, J. H., Chang, Y. C., Yang, Y., Shotelersuk, K., Jung, K. H., Valenti, R., Slader, C., Gao, M., & Park, Y. H. (2021). A Phase Ib Study of Alpelisib or Buparlisib Combined with Tamoxifen Plus Goserelin in Premenopausal Women with HR-Positive HER2-Negative Advanced Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(2), 408–417. https://doi.org/10.1158/1078-0432.CCR-20-1008

9

Wang, C. C., Lin, W. J., Liu, Y. C., Chen, C. C., Wu, S. H., Liu, S. A., & Liang, K. L. (2021). Transoral Robotic Surgery for Pharyngeal and Laryngeal Cancers-A Prospective Medium-Term Study. Journal of clinical medicine, 10(5), 967. https://doi.org/10.3390/jcm10050967

10

Wang, K. L., Fang, C. Y., Lai, W. T., Wang, T. D., Ueng, K. C., Wang, K. Y., Wang, J. H., Shyu, K. G., & Chiang, C. E. (2021). Extended-Release Carvedilol in the Treatment of Hypertension: A Double-Blind, Randomized, Placebo-Controlled Trial. Acta Cardiologica Sinica, 37(2), 186–194. https://doi.org/10.6515/ACS.202103_37(2).20200914B